Celsion Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.56 |
Market Cap |
$35.64 M |
Shares Outstanding |
20.48 M |
Public Float |
18.39 M |
Address |
997 Lenox Drive Lawrenceville New Jersey 08648 United States |
Employees | - |
Website | http://www.celsion.com |
Updated | 07/08/2019 |
Celsion Corp . engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. |